Insider Trading Activity IDEXX Laboratories, Inc. (NASDAQ:IDXX) – Director Bought 2,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Lawrence D Kingsley , Director of IDEXX Laboratories, Inc. (NASDAQ:IDXX) reportedly Bought 2,000 shares of the company’s stock at an average price of 151.76 for a total transaction amount of $303,520.00 SEC Form

Insider Trading History For IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • On 8/8/2012 Merilee Raines, CFO, sold 7,726 with an average share price of $88.84 per share and the total transaction amounting to $686,377.84.View SEC Filing
  • On 9/5/2012 Johnny D Powers, EVP, sold 4,000 with an average share price of $97.12 per share and the total transaction amounting to $388,480.00.View SEC Filing
  • On 11/13/2012 Jonathan W Ayers, CEO, sold 15,000 with an average share price of $89.92 per share and the total transaction amounting to $1,348,800.00.View SEC Filing
  • On 2/4/2013 Merilee Raines, CFO, sold 175,929 with an average share price of $94.25 per share and the total transaction amounting to $16,581,308.25.View SEC Filing
  • On 5/9/2013 Ali Naqui, VP, sold 12,961 with an average share price of $87.00 per share and the total transaction amounting to $1,127,607.00.View SEC Filing
  • On 9/5/2013 Michael J Phd Williams, EVP, sold 5,162 with an average share price of $95.58 per share and the total transaction amounting to $493,383.96.View SEC Filing
  • On 9/13/2013 Johnny Powers, EVP, sold 13,128 with an average share price of $96.59 per share and the total transaction amounting to $1,268,033.52.View SEC Filing

    • Analyst Ratings For IDEXX Laboratories, Inc. (NASDAQ:IDXX)
    These are 2 Sell Ratings, 1 Hold Rating, 3 Buy Ratings .
    The current consensus rating for IDEXX Laboratories, Inc. (NASDAQ:IDXX) is Hold (Score: 2.17) with a consensus target price of $170.75 , a potential (11.89% upside)

    Analyst Ratings History For IDEXX Laboratories, Inc. (NASDAQ:IDXX)

    • On 8/28/2015 Raymond James Financial, Inc. Downgraded rating Outperform to Market Perform
    • On 1/31/2016 William Blair Reiterated Rating Outperform
    • On 2/1/2016 Piper Jaffray Companies Reiterated Rating Neutral with a price target of $73.00 to $75.00
    • On 4/13/2016 Credit Suisse Group Boost Price Target of rating Outperform with a price target of $80.00 to $85.00
    • On 8/3/2016 Northcoast Research Upgraded rating Sell to Neutral
    • On 9/29/2016 Bank of America Corporation Reiterated Rating Neutral
    • On 2/3/2017 Feltl & Co. Downgraded rating Hold to Sell

    Recent Trading Activity for IDEXX Laboratories, Inc. (NASDAQ:IDXX)
    Shares of IDEXX Laboratories, Inc. closed the previous trading session at 152.60 down -1.49 -0.97% with 464,850 shares trading hands.